Anbalcabtagene Autoleucel in Relapsed/Refractory CNS Lymphoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Anbalcabtagene Autoleucel in Relapsed/Refractory CNS Lymphoma	B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 2	2025-12-17		NCT07062627

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Asan Medical Center	114
Hyungwoo Cho	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Asan Medical Center	Seoul	South Korea	338

Clinical trials